The Australian digital medication management company has made it onto the Australian Financial Review’s prestigious annual list
MedAdvisor is ranked 23rd on the Australian Financial Review’s Fast 100 list, featuring the fastest growing companies in Australia for 2018.
This is the first time the organisation has been recognised in the list, reporting an average revenue growth of 84.8% over three years and revenue of $7.39 million.
The company began trading in 2012.
Under the leadership of CEO Robert Read, MedAdvisor has grown as well as expanded to the US.
“We are honoured and proud to be recognised by the AFR as one of the fastest growing companies in Australia,” said Mr Read.
“To be listed #23 amongst the list of other great companies is really humbling.
“MedAdvisor has been at the forefront of ‘Health Tech’ disruption of the health services industry in Australia for over five years and is widely recognised as the pioneer and leading consumer medication management platform in the health space,” he said.
Since its inception in 2013, MedAdvisor has over one million connected users and is utilised by over 55% of community pharmacies across Australia.
“Our vision is to become the leading platform for patients to easily connect with pharmacies, GPs and hospitals for health-related products and services. We have a real commitment to customer-first and everything we do is guided by our company values,” said Mr Read.
Fast 100 entrants must have commenced trading before 1 July 2014, and provide four years of turnover data, with a minimum of $500,000 in the first reporting period (2014-15).
See the full AFR list here
